Answer
Yes. The selected product is licensed to treat tumour-induced hypercalcaemia in adults by reducing calcium release from bone.
Sources for this answer
- Zoledronic acid 4 mg/5 ml concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.